Formic Acid

Formic Acid

SCHEMBL6325278

CCCNC(=O)c1cc(OC)cc(OC)c1.O=CO

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.58
GAA P10253 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.56
MAPT P10636 2/20 0.56
NPC1 O15118 2/20 0.56
RECQL P46063 1/20 0.56
RAB9A P51151 1/20 0.56
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 4/20 0.51
ALDH1A1 P00352 2/20 0.51
TP53 P04637 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.48
RXFP1 Q9HBX9 1/20 0.47
APP P05067 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6359507 0.94 KDM4E (0.65) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL8437113 0.85 KDM4E (0.71) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL6360338 0.84 MAPT (0.67) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL13316205 0.83 GAA (0.53) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL24590212 0.83 MAPT (0.65) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL7799270 0.80 KDM4E (0.69) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL13316204 0.79 MEN1 (0.60) KDM4EGAASMN1; SMN2MAPTNPC1
SCHEMBL6361446 0.78 GAA (0.73) GAASMN1; SMN2MAPTNPC1RAB9A
SCHEMBL6437787 0.77 L3MBTL1 (0.61) KDM4EGAASMN1; SMN2RECQLMEN1
SCHEMBL6360344 0.77 NPC1 (0.75) KDM4ESMN1; SMN2NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1601674-A2 HYDROXY ALKYL SUBSTITUTED 1,3,8-TRIAZASPIRO 4.5]DECAN-4-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF ORL-1 RECEPTOR MEDIATED DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2005-12-07 EP disclosed
WO-2004022558-A2 HYDROXY ALKYL SUBSTITUTED 1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE DERIVATIVES USEFUL FOR THE TREATMENT OF ORL-1 RECEPTOR MEDIATED DISORDERS JANSSEN PHARMACEUTICA, N.V. (BE) 2004-03-18 WO disclosed